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Abstract
Worldwide schistosomiasis continues to be a serious public health problem. Over the past five decades, China has
made remarkable progress in reducing Schistosoma japonicum infections in humans to a relatively low level.
Endemic regions are currently circumscribed in certain core areas where re-infection and repeated chemotherapy
are frequent. At present, selective chemotherapy with praziquantel is one of the main strategies in China’s National
Schistosomiasis Control Program, and thus diagnosis of infected individuals is a key step for such control. In this
paper we review the current status of our knowledge about diagnostic tools for schistosomiasis japonica. A simple,
affordable, sensitive, and specific assay for field diagnosis of schistosomiasis japonica is not yet available, and this
poses great barriers towards full control of schistosomiasis. Hence, a search for a diagnostic approach, which
delivers these characteristics, is essential and should be given high priority.
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Background
Schistosomiasis or ‘bilharzia’ continues to be a serious
public health problem worldwide. The main disease-
causing species are Schistosoma japonicum, S. mansoni,
and S. haematobium, which affect more than 200 mil-
lion people in approximately 70 countries, resulting in a
loss of 1.53 million disability-adjusted life years [1,2].
Schistosomiasis japonica is one of the major tropical dis-
eases in China, with a documented history of > 2,100
years [3]. In the mid 1950s at the beginning of the
National Control Program, schistosomiasis was endemic
in 4,078 townships, belonging to 433 counties/cities of
12 provinces and the estimates of the maximum number
of people infected ranged between 10.5 and 11.8 million
[4,5]. From the mid-1950s to 1980s, comprehensive con-
trol measures were carried out with an emphasis on the
control of the intermediate host i.e. the snail, by means
of environmental management, which targeted the inter-
ruption of transmission. Great success was accomplished
in four out of twelve endemic provinces and in two-
thirds of the endemic counties/cities. Endemic regions
were then circumscribed in certain core areas, such as
the middle and low reaches of the Yangtze River as well
as endemic hilly and mountainous regions in Sichuan
and Yunnan provinces, where achieving sustainable con-
trol is very difficult and the endemic levels fluctuated in
the 1980s [6]. Following the discovery of praziquantel,
the global strategy of schistosomiasis control shifted
from transmission control to morbidity control [7]. In
China the praziquantel-based morbidity control strategy
has been practiced on a large scale in endemic regions
since the 1990s, especially during the 10-year World
Bank Loan Project (WBLP), which ran from 1992 to
2001 [8]. The consequence of such an effective control
program based on mass or selective chemotherapy was a
significant reduction in prevalence and infection intensi-
ties with Schistosoma japonicum in humans [8]. At pre-
sent, selective chemotherapy with praziquantel is one of
the main strategies for control of schistosomiasis in the
National Schistosomiasis Control Program, and thus,
diagnosis is a key factor for schistosomiasis control [9].
Determination of target populations for treatment in the
endemic areas, assessment of morbidity, and the
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tic tests.
In general, S. japonicum infections can be diagnosed by
three different approaches: a) to detect schistosome eggs
in fecal samples by direct parasitological methods or eggs
in tissue biopsies by histological methods; b) to test
immunological responses to certain schistosome antigens
and the levels of parasite-derived antigens in blood and
urine; and c) to measure pathological morbidity asso-
ciated with schistosome infection by clinical, subclinical,
and biochemical markers. There are other methods such
as questionnaires, but their specificity is questionable.
Although the histological method is a sensitive and speci-
fic clinical diagnostic method, it is neither simple nor
convenient for population-based surveys. There are many
methods for measuring the morbidity associated with S.
japonica, e.g. clinical, ultrasonography, but they lack spe-
cificity in some areas such as China.
Direct parasitological examinations
D e t e c t i o no fp a r a s i t ee g g si ns t o o ls a m p l e si sat r a d i -
tional and still widely employed method for diagnosing
schistosome infections. There are many variations of
direct parasitological examinations, but the Kato-Katz
thick smear (KK) [10] and the miracidium hatching test
(MHT) [11] are the two most widely used in the field in
China.
The KK method is the most extensively used method
for diagnosing S. japonica in field surveys because it is
quantitative, relatively inexpensive, and simple. However,
it has become relatively insensitive following widespread
chemotherapy, which results in generally low worm bur-
dens [12]. The specificity and positive predictive value
(PPV) of the KK method are good irrespective of the
reference gold standards and the infection rates in
humans, but the sensitivities of the KK method vary
from 40% to 100%, and the negative predictive values
(NPV) of the KK method range from 52.5% to 100%
(Table 1) [13-20]. Table 1[13-20] shows that the last
two parameters (sensitivity and NPV) of the KK method
are highly dependent on the prevalence of infection
among the population, and the two parameters of the
KK method decrease generally with a decrease of preva-
lence in humans. For example, using the two repeated
Kato-Katz results as the reference gold standard, the
sensitivity of a single stool examination with the three-
slide Kato-Katz method was 68.4% - 70.0% in Village A,
with an infection rate of 18.6% and 59.6%-69.2% in Vil-
lage B with a prevalence of 6.6%, respectively [14]. Thus,
more than 30% of infected people are misdiagnosed by
the Kato-Katz method in endemic regions in China,
who are likely to be missed in treatment and continue
to serve as infection sources.
The miracidium hatching test is another traditional
approach for assessing S. japonicum infection and has
been used widely in China for more than five decades
[21]. The test is initiated by the concentration of eggs
from feces through a nylon tissue bag and suspension in
Table 1 Sensitivity, specificity and predictive value of KK and MHT methods for diagnosing S. japonicum infection
Method Sensitivity
(%)
Specificity
(%)
*PPV
(%)
*NPV
(%)
*Prevalence
(%)
Reference gold standard Author and date of
publication
*KK 51.1-84.1 100 100 93.2-96.5 13.0-18.4 two repeated KK results (6 slides) Lin et al. 2008 [13]
59.6-70.0 100 100 93.3-97.9 6.6-18.6 two repeated KK results (6 slides) Zhou et al. 2007 [14]
72.2-100.0 100 100 96.3-
100.0
6.2-12.0 combined results of KK(3 slides) and
MHT
Xu et al. 2007 [15]
58.3 100 100 83.5 32.1 MHT He et al. 2007 [16]
67.6 100 100 58.9 68.3 seven repeated KK examinations (14
slides)
Yu et al. 2007 [17]
69.9 100 100 95.63 13.2 combined results of KK(3 slides) and
MHT
Zhu et al. 2005 [18]
50.0 100 100 98.02 3.9 combined results of KK(3 slides) and
MHT
Song et al. 2003 [19]
40-68 100 100 52.5-80.5 36.0-68.3 seven accumulated KK results(14 slides) Yu et al. 1998 [20]
*MHT 24.0-95.0 100 100 95.2-99.6 6.2-12.0 combined results of KK (3 slides) and
MHT
Xu et al.2007 [15]
79.2 100 100 94.0 23.6 KK(3 slides) He et al. 2007 [16]
32.8 100 100 40.9 68.3 seven accumulated KK results (14 slides) Yu et al. 2007 [17]
89.8 100 100 98.5 13.2 combined results of KK(3 slides) and
MHT
Zhu et al.2005 [18]
94.4 100 100 99.8 3.9 combined results of KK(3 slides) and
MHT
Song et al. 2003 [19]
*PPV = Positive predictive value; *NPV = Negative predictive value; *KK = The Kato-Katz thick smear stool examination; *MHT = Miracidium hatching test;
*Prevalence is calculated based on the reference gold standard
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Page 2 of 7distilled water. Miracidia that hatch from ova are visua-
lized microscopically, and their presence is an indication
of infection. The specificity and PPV of the MHT
method are high and identical irrespective of the refer-
ence gold standards and the infection rates amongst the
population, however, the sensitivities of the MHT
method range from 24.0% to 95.0%, and the NPV of the
MHT method varies from 40.9% to 99.6% (Table 1)
[15-19]. The variation range of both the sensitivity and
NPV of the MHT method was larger than that of the
KK method (Table 1) [13-20]. As shown in Table 1
[15-19], the result of the hatching test is unstable, and is
highly dependent on the infection prevalence among the
population and environmental factors such as tempera-
ture and water quality (e.g. pH). For example, when the
combined results of seven repeated Kato-Katz examina-
tions and hatching tests were used as the gold standard,
the sensitivity of the hatching test was only 32.8% (less
than 67.6% for a single Kato-Katz examination) in Zhuxi
Village, while in Zhonjiang Village, the hatching test
detected more positive cases than the Kato-Katz test did
(prevalence 31% vs. 24%) [20]. This method has not
been standardized for quantitative measurement,
whereas, the KK method can obtain egg counts (EPG,
eggs per gramme of feces) which gives an indication of
infection intensity (useful information for control pro-
grams), more importantly, even under optimal condi-
tions, only 50% to 70% of eggs will hatch, with light
infections being missed [17,22].
Ideally multiple stool examinations should be per-
formed in order to reduce the false-negative results;
however, repeated stool collection and examination
require a lot of time and manpower. Thus, it is imprac-
tical to initiate such a strategy at the national level for
routine schistosomiasis control programs. As an ideal
field method for the detection of schistosome eggs in
stool samples is still not available, the use of traditional
parasitological tests poses a great challenge in identify-
ing infected cases particularly in low transmission
settings.
Indirect immunological techniques
Indirect immunodiagnostic assays, i.e. detection of schis-
tosome-specific antibodies, have a long history in China.
There are many variations of indirect immunological
methods [23]. However, Circumoval Precipitin Test
(COPT), and Indirect Hemagglutination Assay (IHA)
are historically the most widely used immunodiagnostic
tests in China, while various forms of Enzyme-linked
immunosorbent assay (ELISA) and Dipstick dye immu-
noassay (DDIA) have become more important over the
past 10-20 years [23].
COPT has been widely used in China for almost 50
years [24] and undergone a series of modifications
including the application of a variety of labelling techni-
ques in attempts to standardize the testing system
including antigen preparation and testing protocol. The
COPT has a high sensitivity (94.1%-98.6%) and a low
false-positive rate (2.5%-3.6%) in healthy people from a
non-endemic area [25]. However, with repeated che-
motherapy in the endemic areas, the sensitivity of this
method decreased to 72.2% - 85.8% (Table 2) [16,19,26].
The NPV of the COPT method is high (more than
87%), but the PPV of this method is low (from 31.7% to
74.9%) (Table 2) [16,19,26]. In addition, this assay is
time-consuming and comparatively complicated and
requires microscopy, limiting its wide application in
China.
T h eI H Aw i t hs o l u b l ee x t r acts of schistosome eggs
was developed and applied in late the 1960s, and is sec-
ondary only to COPT in its long history of use in
China. Currently, the IHA method is still an extensively
employed method for community diagnosis and screen-
ing of people targeted for chemotherapy, owing to its
relatively high sensitivity, simplicity and rapidity in field
use compared with the KK and MHT methods. How-
ever, with repeated chemotherapy in the endemic areas,
the PPV of the IHA method is low, and most reported
PPVs are less than 37% (Table 2) [14,15,17,27-31]. The
sensitivity of the IHA method varies from 69.7% to
100.0%, and its specificity ranges from 35.7% to 93.6%
(Table 2) [14,15,17,27-31]. In addition, the cross-reac-
tion with Paragonimus westermani was 64%-84% with
soluble egg antigen (SEA) and 31.3% with purified egg
antigen [32]. These disturb its continued wide applica-
tion in China.
ELISA was first described by Engvall and Perlmann
[33]. In the late 1970s, the classical ELISA using crude
antigens of the parasite emerged for the diagnosis of
schistosomiasis, this was regarded as the tool being
most likely to meet stringent requirements for field use
in terms of reliability, sensitivity, and specificity; in the
following years many different variations have been
developed for field uses (e.g. Dot-ELISA, SPA-ELISA).
Table 3[13-16,19,26,27,30,34] summarizes the sensitivity,
specificity, and predictive value of the ELISA method for
diagnosing S. japonicum infection. The sensitivity of this
method varies from 65.5% to 100%, whilst most reported
specificities of this method are less than 60% (Table 3)
[13-16,19,26,27,30,34]. The NPV of the ELISA method
is high ( > 88.0%), but most of the reported PPVs of this
method are very low. Although this technique has rela-
tively high sensitivity, an ELISA reader is required to
process samples and the delay time (e.g. from sample
processing to result reading) is usually 2-3 hours.
A meta-analysis [35] showed that the sensitivity ran-
ged from 40.7% to 95.1% for IHA, from 23.3% to 97.3%
for ELISA; the false positive rate was 11.0% to 55.6% of
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Method Sensitivity
(%)
Specificity
(%)
*PPV
(%)
*NPV
(%)
*Prevalence
(%)
Reference gold standard Author and date of
publication
*COPT 85.8 54.1 36.6 92.5 23.6 KK (3 slides) He et al. 2007 [16]
82.8 57.7 48.1 87.7 32.1 MHT He et al. 2007 [16]
85.2 95.6 74.9 97.7 13.4 MHT Zhu et al. 2005 [26]
72.2 93.7 31.7 98.8 3.9 combined results of KK (3 slides) and
MHT
Song et al. 2003 [19]
*IHA 80.0 93.6 18.8 99.6 1.7 MHT Zhang et al. 2010 [27]
69.7 89.4 36.8 96.8 8.9 two repeated KK results (12 slides) Lin et al. 2008 [28]
97-100 60-77 19-30 100.0 3.1-14.2 KK examination (3 slides) Zhou et al. 2008 [29]
83.7-92.3 55.8-67.3 16.6-
30.2
93.7-99.2 6.6-18.6 two repeated KK results (6 slides) Zhou et al. 2007 [14]
76.0-85.6 35.7-63.6 8.9-22.2 94.8-97.7 6.2-12.0 combined results of KK (3 slides) and
MHT
Xu et al. 2007 [15]
80.3 48.4 77.0 53.3 68.3 seven repeated KK examinations (14
slides)
Yu et al. 2007 [17]
66.7-100.0 67.6-91.6 2.9-15.8 97.6-
100.0
0.3-5.7 two repeated KK results (6 slides) Wang et al.2006 [30]
82.1 71.1 26.8 96.9 9.2 KK (3 slides) Li et al. 2002 [31]
*PPV = Positive predictive value; *NPV = Negative predictive value; *COPT = Circumoval precipitin test; *IHA = Indirect hemagglutination assay;
*Prevalence is calculated based on the reference gold standard
Table 3 Sensitivity, specificity and predictive value of ELISA and DDIA methods for diagnosing S. japonicum infection
Method Sensitivity
(%)
Specificity
(%)
*PPV
(%)
*NPV
(%)
*Prevalence
(%)
Reference gold standard Author and date of
publication
*ELISA 80.0 81.6 7.1 99.57 1.7 MHT Zhang et al. 2010 [27]
79.3-87.4 38.9-53.5 20.8-
24.6
93.1-
94.4
13.3-18.5 two repeated KK results (6 slides) Lin et al.2008 [13]
88.4-96.2 38.4 9.9-
24.7
93.5-
99.3
6.6-18.6 two repeated KK results (6 slides) Zhou et al. 2007 [14]
95.0 20.4 26.9 93.0 23.6 KK (3 slides) He et al.2007 [16]
98.2 23.8 37.9 96.6 32.1 MHT He et al. 2007 [16]
65.8 51.7 8.3-
15.7
91.7-
95.8
6.2-12.0 combined results of KK (3 slides) and MHT Xu et al.2007 [15]
65.5 59.4 12.7 95.0 8.3 combined results of three repeated KK (12
slides) and MHT
Chen et al.2007 [34]
88.9-100.0 43.2-92.2 3.1-
18.6
99.2-
100.0
0.3-5.7 two repeated KK results (6 slides) Wang et al.2006 [30]
92.1 90.4 59.6 98.7 13.4 MHT Zhu et al.2005 [26]
83.3 84.3 77.2 88.8 3.9 combined results of KK (3 slides) and MHT Song et al.2003 [19]
*DDIA 75.0-95.5 37.2-78.7 0.5-
18.4
98.6-
99.9
0.4-8.2 combined results of KK (3 slides) and MHT Xu et et al. 2011 [38]
80.0 92.2 15.5 99.6 1.7 MHT Zhang et al. 2010 [27]
75.3 55.1 10.0-
18.6
94.2-
97.1
6.2-12.0 combined results of KK (3 slides) and MHT Xu et al.2007 [15]
95.1 37.4 41.8 94.2 32.1 MHT He et al.,2007 [16]
92.5 33.0 29.9 93.4 23.6 KK (3 slides) He et al.2007 [16]
44.8 69.8 87.6 21.0 8.3 combined results of three repeated KK (12
slides) and MHT
Chen et al. 2007 [34]
96.6 96.3 80.2 99.5 13.4 MHT Zhu et al.2005 [26]
94.4 87.4 23.3 99.7 3.9 combined results of KK (3 slides) and MHT Song et al.2003 [19]
94.9 40.8 17.1 98.4 9.2 KK (3 slides) Li et al. 2002 [31]
*PPV = Positive predictive value; *NPV = Negative predictive value; * ELISA = Enzyme-linked immunosorbent assay; *DDIA = Dipstick dye immunoassay;
*Prevalence is calculated based on the reference gold standard
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Page 4 of 7IHA and 16.3% to 79.6% of ELISA, and the results of
the meta-analysis indicated that IHA had more prefer-
able diagnostic properties than the ELISA.
The DDIA, a new immunodiagnostic assay, has been
developed in recent years [36,37]. This method is basi-
c a l l yac h r o m a t o g r a p h yt e c h n i q u eu s i n gs o l u b l ee g g
antigen (SEA) of S. japonicum, labeled with a dye as the
indicator system. Table 3[15,16,19,26,27,31,34,38] shows
that the sensitivity and NPV of the DDIA method are
high (≥75% for sensitivity, > 94% for NPV) except for
one report [34], but the reference gold standard of this
report is closer to the ‘true’ than that of other reports.
The specificity and PPV of this method show very large
discrepancies, e.g. the specificity is from 33.0% to 96.3%
and PPV ranges from 0.5% to 87.6% (Table 3)
[15,16,19,26,27,31,34,38]. In addition, the DDLA has a
high cross-reaction with paragonimiasis (70.0%) [36].
Although most of the reported sensitivities and NPV
of these antibody detection assays were relatively high,
the discrepancy in both the reported specificities and
reported PPV of these methods was very large, and
moreover, most of these reported specificities and PPV
were very low (Table 2, Table 3) [13-17,19,26-31,34,38].
This discrepancy may be attributed to the following fac-
tors [35]: (a) the choice of the reference gold standard.
Examination for parasite eggs in excreta are often used
as the gold standard when evaluating the performance
of immunodiagnostic tests for schistosome infections
[12], of the parasitological examinations, KK and MHT
methods, or combined results of KK and MHT are
often used as gold standards when testing immunologi-
cal techniques in China, particularly in population-based
studies, the number of the Kato-Katz thick smears
examined ranged from 3 slides to 14 slides (Table 2,
Table 3) [13-17,19,26-31,34,38]. More ‘true’ infections
were observed in an endemic area with an increase of
the number of KK thick smears being examined due to
the low sensitivity of the KK method [13]. So, the differ-
ence in both reported specificities and reported PPV of
an immunodiagnostic method were large when the dif-
ferent tests (KK, MHT or combined results of KK and
MHT) were used as a gold standard. Hence, an appro-
priate gold standard for testing field-applied immunolo-
gical techniques would be the use of multiple stool
examinations, for example, repeated KK examinations or
the KK method combined with the MHT method; (b)
infection prevalence and intensity in a community; (c)
different diagnostic agents of schistosomiasis; and (d)
size of the sample. The low specificity is likely to result
in a high ‘false-seropositivity’, i.e. the high proportion of
seropositive individuals were classified into negative
groups of stool examination in endemic regions, espe-
cially in the areas with relatively high endemicity, where
re-infection and repeated chemotherapy are very
common. For example, the false-positive rate of IHA
was 44.2% in a village with a prevalence of 18.6%, and
32.7% in another village with a prevalence of 6.6%, while
that of ELISA assays was higher (61.6%), when the two
accumulated Katz-Kato results were designated as the
gold standard [14]. Apart from the low specificity and
PPV, these assays have generally a high cross-reaction
with other parasites e.g. P. westermani [22]. Among all
obstacles of antibody-based immunodiagnostic tests, the
major one is that these currently available assays cannot
distinguish active infectionf r o mp r e v i o u si n f e c t i o no r
re-infection, which results in a high false-positive,
thereby causing difficulties in identifying infected indivi-
duals for selective chemotherapy, and assessing the
effectiveness of intervention.
Direct immunological tests
Previously, schistosome-derived antigens, through
immunoassays, were shown to be present in the circu-
lation and/or excreta of infected hosts [39], prompting
considerable research on their potential for immuno-
diagnosis of schistosomiasis. In the early 1980s,
research was initiated first by Qian and Deelder [40] to
explore detection of the circulating anodic antigen
(CAA) for immunodiagnosis of S. japonicum infection
in China. The results demonstrated that the detection
l i m i tw a sf r o m1 0t o0 . 5 - 0 . 2 5n g / m lb yu s eo fm o n o -
clonal antibody (mAb)-defined CAA series. Thus far, a
lot of testing systems based on monoclonal or polyclo-
nal antibodies for detection of different target antigens
had been developed in more than 10 laboratories in
China.
In 1993, a collaborative study focusing on evaluation
testing systems for antigen detection was conducted in
China [41]. The results showed that most tests involved
in the detection of different circulating antigens were
not satisfactory, showing high false seroreactivity ran-
ging from 24 to 46% and low sensitivity ranging from 15
to 73% in chronic and light infections [41]. Afterwards a
special national program was carried out. This was
aimed at improving the diagnostic capacity of existing
assays and also seeking novel probes with emphasis on
those that could be promising for the use of monitoring
the efficacy of chemotherapy. This was initiated under
the supervision of the Schistosomiasis Expert Advisory
Committee, Ministry of Health. Then in 1995, 14 testing
systems, of which 13 for antigen detection and 1 for
antibody detection, from 12 laboratories were brought
to Wuhan city for a collaborative evaluation [42].
Among the 13 assays for antigen detection, 9 showed
high specificity with above 90% but only 3 of the assays
gave above 68% sensitivity, of which the highest was
81%, in chronic and light infections. Furthermore, there
was also no clear-cut evidence that antigen-based assays
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intensity [41].
Conclusion
Pressing need for improved diagnostics
After five decades’ of effort, China has made great achieve-
ments in schistosomiasis control and the infection preva-
lence and intensity of schistosomiasis in humans have
decreased to a relatively low level [6,8]. The achievement,
to a large extent, is attributable to praziquantel-based che-
motherapy, and prompts an increasing understanding of
the need for sufficiently sensitive and specific diagnostic or
screening techniques of schistosomiasis in low transmis-
sion settings. However, we are currently in a diagnostic
dilemma for S. japonica - the direct parasitological techni-
ques have become relatively insensitive due to widespread
chemotherapy that results in generally low worm burdens,
which leads to less efficiency in low transmission settings
and in post-treatment situations [14,17,20]. Other diagnos-
tic alternatives include detection of antibodies or circulat-
ing antigens in serum. Antibody detection assays with
relatively high sensitivity but generally low specificity, do
not differentiate between current and cured infections,
which results in the difficulties in determining prevalence,
identifying true infected individuals for selective che-
motherapy and assessing the effectiveness of intervention
including follow-up of chemotherapy. The detection of
circulating antigens is a highly specific assay, but has not
been shown to be more sensitive than the detection of
eggs in areas of low endemicity [42-45]. Therefore, it is
very difficult to select the most appropriate diagnostic
detection methods for S japonicum in the areas where re-
infection and repeated chemotherapy are frequent [14].
On the one hand, if every person with a positive result
from antibody-based immunodiagnostic assays is treated
with praziquantel year after year, a considerable number
of previous infections will be treated repeatedly, which
results in inappropriate use of praziquantel and reduction
in chemotherapy compliance [14]. On the other hand, if
these immunodiagnostic assays are only used for prelimin-
ary screening and all those with positive results of immu-
nodiagnostic assays are subject to stool examination to
confirm infection, then only the individuals with positive
egg counts are treated, a higher proportion of infections
may be missed by this method than by using only the fecal
examination [14]. It is suggested that the insensitivity or
non-specificity of currently applied diagnostic methods
conspire to produce inaccurate estimates of disease
impact, and this threatens the successful drive towards full
control of schistosomiasis [46]. Hence, the search for a
robust diagnostic test that can be applied in field situations
is essential and should be given high priority.
Recently, polymerase chain reaction (PCR) based assays
have been developed to detect S. mansoni, S. haematobium
and S. japonicum infections, and have shown potential as a
highly sensitive and specific technique for detection of
parasite DNA in feces or sera and plasma, especially in
regions with low intensity infections [47-54].
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